• Cancer and genetic diseases affect more than 30 million people

    Our mission is to accelerate the development of innovative therapeutics through RNA splicing analysis and artificial intelligence.

    15%

    of all disease-causing mutations are predicted to disrupt RNA splicing.

    370

    known genetic disorders in publications are caused by RNA splicing errors.

    50%

    of synonymous cancer-driver mutations disrupt RNA splicing.

  • SpliceCore

    Artificial Intelligence Platform for Drug Discovery

  • Investors

    Third Kind Venture Capital
    Dolby Family Ventures
    SBIR
    Accelerate Long Island
    Dynamk Capital
    National Institutes of Health
    SV Angel
    Breakout Labs
    Empire State Development
    Topspin
  • Partners

    Amazon Web Services
    Google Cloud Platform
    Microsoft
  • @envisagenics